US 7582759
Diastereomeric purification of rosuvastatin
granted A61PA61P3/06
Quick answer
US patent 7582759 (Diastereomeric purification of rosuvastatin) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P3/06